ATE384743T1 - Aminoterminal modifizierte parathyroidhormon (pth) analoge - Google Patents
Aminoterminal modifizierte parathyroidhormon (pth) analogeInfo
- Publication number
- ATE384743T1 ATE384743T1 AT99962819T AT99962819T ATE384743T1 AT E384743 T1 ATE384743 T1 AT E384743T1 AT 99962819 T AT99962819 T AT 99962819T AT 99962819 T AT99962819 T AT 99962819T AT E384743 T1 ATE384743 T1 AT E384743T1
- Authority
- AT
- Austria
- Prior art keywords
- pth
- desamino
- aminoterminal
- analogue
- parathyroid hormone
- Prior art date
Links
- 108090000445 Parathyroid hormone Proteins 0.000 title abstract 3
- 102000003982 Parathyroid hormone Human genes 0.000 title 2
- 239000000199 parathyroid hormone Substances 0.000 title 2
- 229960001319 parathyroid hormone Drugs 0.000 title 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 150000001413 amino acids Chemical group 0.000 abstract 2
- 102100030869 Parathyroid hormone 2 receptor Human genes 0.000 abstract 1
- 101710149426 Parathyroid hormone 2 receptor Proteins 0.000 abstract 1
- 102100032256 Parathyroid hormone/parathyroid hormone-related peptide receptor Human genes 0.000 abstract 1
- 101710180613 Parathyroid hormone/parathyroid hormone-related peptide receptor Proteins 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 108091002540 human parathyroid hormone (1-31)amide Proteins 0.000 abstract 1
- 102000032129 human parathyroid hormone (1-31)amide Human genes 0.000 abstract 1
- OXZNHYPGOAWYLT-FISSOZIDSA-N ostabolin Chemical compound C([C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1N=CN=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)OC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CCC(O)=O)C(C)C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(N)=N)C(C)C)C1C=NC=N1 OXZNHYPGOAWYLT-FISSOZIDSA-N 0.000 abstract 1
- 108010067557 parathyroid hormone (1-34)amide Proteins 0.000 abstract 1
- RRBCHMCWWOHRQL-UMXFMPSGSA-N parathyroid hormone (1-34)amide Chemical compound C([C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)C1=CN=CN1 RRBCHMCWWOHRQL-UMXFMPSGSA-N 0.000 abstract 1
- 239000000018 receptor agonist Substances 0.000 abstract 1
- 229940044601 receptor agonist Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Endocrinology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11015298P | 1998-11-25 | 1998-11-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE384743T1 true ATE384743T1 (de) | 2008-02-15 |
Family
ID=22331485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99962819T ATE384743T1 (de) | 1998-11-25 | 1999-11-23 | Aminoterminal modifizierte parathyroidhormon (pth) analoge |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US6537965B1 (de) |
| EP (1) | EP1175444B1 (de) |
| JP (1) | JP2003533167A (de) |
| AT (1) | ATE384743T1 (de) |
| AU (1) | AU1918300A (de) |
| DE (1) | DE69938064T2 (de) |
| WO (1) | WO2000031137A1 (de) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4486256B2 (ja) * | 1998-10-22 | 2010-06-23 | ザ・ジェネラル・ホスピタル・コーポレイション | 副甲状腺ホルモン（ＰＴＨ）および副甲状腺ホルモン関連ペプチド（ＰＴＨｒＰ）の生物活性ペプチドおよびペプチド誘導体 |
| AU1633200A (en) * | 1998-11-25 | 2000-06-13 | General Hospital Corporation, The | Human parathyroid hormone modifications, preparation and use |
| AU4217299A (en) * | 1998-11-30 | 2000-06-19 | General Hospital Corporation, The | Pth1r and pth3r receptors, methods and uses thereof |
| US7057012B1 (en) * | 1998-12-31 | 2006-06-06 | The General Hospital Corporation | PTH functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules |
| DK1141237T3 (da) * | 1998-12-31 | 2006-02-13 | Gen Hospital Corp | PTH-receptor og screeningsassay der anvender denne |
| DE69939275D1 (de) * | 1998-12-31 | 2008-09-18 | Gen Hospital Corp | Peptide, bestehend aus zwei funktionellen PTH-Domänen, die durch ein Linkermolekül verknüpft sind, und Derivate davon |
| AU7734800A (en) * | 1999-09-29 | 2001-04-30 | General Hospital Corporation, The | Polypeptide derivatives of parathyroid hormone (pth) |
| US6756480B2 (en) | 2000-04-27 | 2004-06-29 | Amgen Inc. | Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| AU2001292905A1 (en) * | 2000-09-19 | 2002-04-02 | Curagen Corporation | Method of identifying osteoregenerative agents using differential gene expression |
| KR100491737B1 (ko) * | 2001-07-20 | 2005-05-27 | 주식회사 한국아이템개발 | 공기 정화 기능의 모기 퇴치기 |
| US7572765B2 (en) | 2001-07-23 | 2009-08-11 | The General Hospital Corporation | Conformationally constrained parathyroid hormone (PTH) analogs |
| MXPA04001418A (es) * | 2001-08-17 | 2004-05-27 | Novartis Ag | Acido n-(5-clorosalociloil)-8-aminocaprilico como agente de suministro oral para fragmentos de hormona paratiroides. |
| EP1513547A4 (de) | 2002-05-23 | 2009-11-04 | Michael F Holick | Verwendung von parathormone-peptid-analoga zur behandlung von scheidenatrophie |
| US7799757B2 (en) * | 2002-06-13 | 2010-09-21 | Michael Chorev | Analogs of parathyroid hormone and PTH-related protein as bone anabolic agents |
| AU2002951372A0 (en) * | 2002-09-13 | 2002-09-26 | St Vincent's Institute Of Medical Research | Parathyroid hormone-like polypeptides |
| US8088734B2 (en) | 2003-01-21 | 2012-01-03 | Unigene Laboratories Inc. | Oral delivery of peptides |
| AU2003220380A1 (en) * | 2003-03-19 | 2004-11-19 | Bristol-Myers Squibb Company | CONFORMATIONALLY CONSTRAINED PARATHYROID HORMONES WITH Alpha-HELIX STABILIZERS |
| BRPI0412664A (pt) * | 2003-07-15 | 2006-09-26 | Ca Nat Research Council | método para tratar uma condição caracterizada por hiperproliferação de células da pele em um indivìduo em risco ou portador dessa condição e utilização de uma quantidade terapeuticamente efetiva de um análogo cìclico de hormÈnio de paratireóide humano (hpth) |
| JP4871128B2 (ja) * | 2003-07-17 | 2012-02-08 | ザ ジェネラル ホスピタル コーポレイション | 高次構造的に制約された副甲状腺ホルモン（ｐｔｈ）アナログ |
| AU2005244734A1 (en) * | 2004-05-13 | 2005-12-01 | Alza Corporation | Apparatus and method for transdermal delivery of parathyroid hormone agents |
| WO2008019062A2 (en) * | 2006-08-04 | 2008-02-14 | The General Hospital Corporation | Polypeptide derivatives of parathyroid hormone (pth) |
| EP1961765A1 (de) * | 2006-12-08 | 2008-08-27 | Zealand Pharma A/S | Verkürzte PTH-Peptide mit zyklischer Konformation |
| US20090023655A1 (en) * | 2007-04-02 | 2009-01-22 | Louis Luttrell | Biased Ligands for Receptors Such as the PTH Receptor |
| CN104072606B (zh) | 2007-08-01 | 2017-09-22 | 总医院有限公司 | 利用g蛋白偶联受体和相关组合物的筛选方法 |
| US8563513B2 (en) | 2009-03-27 | 2013-10-22 | Van Andel Research Institute | Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use |
| BR112012028949B1 (pt) | 2010-05-13 | 2020-11-17 | Chugai Seiyaku Kabushiki Kaisha | polipeptídeo análogo do hormônio paratireoideo, seu uso e método de produção, bem como ácido nucleico, vetor de expressão, célula e composição farmacêutica |
| EP3765061A4 (de) | 2018-03-16 | 2022-01-26 | The General Hospital Corporation | Parathormon-polypeptidkonjugate und verfahren zu deren verwendung |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5896052A (ja) * | 1981-11-30 | 1983-06-07 | Toyo Jozo Co Ltd | 高活性ｈ−ＰＴＨ（１−３４）アミドの製造法 |
| US4423037A (en) * | 1982-05-13 | 1983-12-27 | The General Hospital Corporation | Inhibitors of peptide hormone action |
| JPS59204159A (ja) * | 1983-04-28 | 1984-11-19 | Toyo Jozo Co Ltd | 〔Ｍｅｔ（Ｏ）↑８’↑１↑８〕ｈＰＴＨ−（１−３４）ペプチド |
| IL78342A (en) * | 1985-04-04 | 1991-06-10 | Gen Hospital Corp | Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof |
| US5527772A (en) | 1987-10-20 | 1996-06-18 | Holick; Michael F. | Regulation of cell proliferation and differentiation using peptides |
| US5605815A (en) * | 1988-03-14 | 1997-02-25 | Yale University | Nucleic acids encoding and expression of parathyroid hormone-like peptide |
| US5350836A (en) * | 1989-10-12 | 1994-09-27 | Ohio University | Growth hormone antagonists |
| US5814603A (en) * | 1992-06-12 | 1998-09-29 | Affymax Technologies N.V. | Compounds with PTH activity |
| US5589452A (en) * | 1992-07-14 | 1996-12-31 | Syntex (U.S.A.) Inc. | Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
| JP4486256B2 (ja) * | 1998-10-22 | 2010-06-23 | ザ・ジェネラル・ホスピタル・コーポレイション | 副甲状腺ホルモン（ＰＴＨ）および副甲状腺ホルモン関連ペプチド（ＰＴＨｒＰ）の生物活性ペプチドおよびペプチド誘導体 |
| AU1633200A (en) * | 1998-11-25 | 2000-06-13 | General Hospital Corporation, The | Human parathyroid hormone modifications, preparation and use |
| AU4217299A (en) * | 1998-11-30 | 2000-06-19 | General Hospital Corporation, The | Pth1r and pth3r receptors, methods and uses thereof |
-
1999
- 1999-11-23 US US09/447,800 patent/US6537965B1/en not_active Expired - Fee Related
- 1999-11-23 WO PCT/US1999/027656 patent/WO2000031137A1/en active IP Right Grant
- 1999-11-23 DE DE69938064T patent/DE69938064T2/de not_active Expired - Lifetime
- 1999-11-23 EP EP99962819A patent/EP1175444B1/de not_active Expired - Lifetime
- 1999-11-23 AT AT99962819T patent/ATE384743T1/de not_active IP Right Cessation
- 1999-11-23 JP JP2000583963A patent/JP2003533167A/ja active Pending
- 1999-11-23 AU AU19183/00A patent/AU1918300A/en not_active Abandoned
-
2003
- 2003-02-11 US US10/361,928 patent/US20030144209A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE69938064D1 (de) | 2008-03-13 |
| EP1175444B1 (de) | 2008-01-23 |
| AU1918300A (en) | 2000-06-13 |
| EP1175444A1 (de) | 2002-01-30 |
| US20030144209A1 (en) | 2003-07-31 |
| US6537965B1 (en) | 2003-03-25 |
| WO2000031137A1 (en) | 2000-06-02 |
| JP2003533167A (ja) | 2003-11-11 |
| DE69938064T2 (de) | 2009-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE384743T1 (de) | Aminoterminal modifizierte parathyroidhormon (pth) analoge | |
| HK1040738A1 (en) | Human parathyroid hormone modifications, preparation and use | |
| ES2329233T3 (es) | Analogos de la hormona paratiroidea. | |
| USRE40850E1 (en) | Analogs of parathyroid hormone | |
| KR100699422B1 (ko) | 부갑상선 호르몬의 동족체 | |
| Abou-Samra et al. | Non-Homologous Sequences of Parathyroid Hormone and the Parathyroid Hormone Related Peptide Bind to a CommonReceptor on ROS 17/2.8 Cells | |
| US7410948B2 (en) | Analogs of parathyroid hormone | |
| TN2009000313A1 (en) | Glucagon/glp - 1 receptor co-agonists | |
| ATE304020T1 (de) | Parathyroidhormon-verwandthe peptidanaloge | |
| EA019203B9 (ru) | Коагонисты глюкагонового рецептора/glp-1-рецептора | |
| HUP0004560A2 (hu) | Törést gyógyító PTHrP analógok | |
| Gardella et al. | Expression of human parathyroid hormone-(1-84) in Escherichia coli as a factor X-cleavable fusion protein. | |
| EP0965637A4 (de) | Fas ANTIGEN-DERIVATE | |
| AR008094A1 (es) | Proceso para la sintesis de un polipeptido sintetico analogo a la hormona paratiroidea o al peptido relacionado con la hormona paratiroidea y procesopara la preparacion de una composicion farmaceutica. | |
| WO2004093902A1 (en) | CONFORMATIONALLY CONSTRAINED PARATHYROID HORMONES WITH α-HELIX STABILIZERS | |
| CO5560586A2 (es) | Acido n-(5-clorosaliciloil)-8-aminocaprilico como agente de suministro oral para fragmentos de hormona paratiroides | |
| EP0773958A1 (de) | PTH ODER PTHrP ANTAGONISTEN | |
| NO20012232L (no) | Enzymatisk amidering av peptider | |
| GB0001712D0 (en) | Therapeutic peptides | |
| WO2003097690A2 (en) | Pth derivatives resistant to skin proteases | |
| EP1219638A3 (de) | G-Protein gekoppelte Rezeptoren welche Homologie zum P2Y Purinoreceptor 1 (P2Y1) aufweisen | |
| EP1096008A3 (de) | Menschlicher G-Protein-gekoppelter Rezeptor, PFI-014 | |
| UA104842C2 (uk) | Ненативний глюкагоновий пептид |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |